Assyro AI

FDA Orange Book · active-ingredient family

Desvenlafaxine fumarate

Desvenlafaxine fumarate is approved in 2 FDA applications, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:DESVENLAFAXINE · NDA 205583

2

Brand (NDA)

0

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet, extended release

ProductApplicantApplicationTEApproved
DESVENLAFAXINERLD×2SUN PHARMNDA 205583Jan 28, 2014
DESVENLAFAXINE×2TEVA PHARMS USANDA 205208Oct 11, 2013

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Desvenlafaxine fumarate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.